GSA CAPITAL PARTNERS LLP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$619
-37.7%
189,751
+1.2%
0.04%
-45.6%
Q1 2024$994
-12.5%
187,585
-28.5%
0.08%
-17.7%
Q4 2023$1,136
+54.6%
262,337
-6.2%
0.10%
+52.4%
Q3 2023$735
+81.5%
279,629
+143.8%
0.06%
+57.5%
Q2 2023$405
+31.1%
114,698
+57.2%
0.04%
+5.3%
Q4 2022$309
-99.9%
72,940
-48.0%
0.04%
-13.6%
Q3 2022$333,000
+69.9%
140,321
+104.1%
0.04%
+51.7%
Q2 2022$196,000
-51.0%
68,749
-50.5%
0.03%
-46.3%
Q1 2022$400,000
-33.7%
138,943
+61.5%
0.05%
-11.5%
Q3 2021$603,000
+340.1%
86,040
+478.0%
0.06%
+306.7%
Q2 2021$137,000
-81.3%
14,885
-82.2%
0.02%
-82.4%
Q4 2019$732,000
+177.3%
83,686
+241.6%
0.08%
+136.1%
Q3 2019$264,000
-30.2%
24,500
-17.6%
0.04%
-14.3%
Q2 2019$378,000
+51.2%
29,718
+361.8%
0.04%
+68.0%
Q1 2019$250,000
-93.8%
6,435
-81.4%
0.02%
-83.9%
Q2 2015$4,042,000
+54.0%
34,625
+211.5%
0.16%
+49.0%
Q1 2015$2,624,000
+202.0%
11,114
+142.0%
0.10%
+70.5%
Q4 2014$869,000
-55.0%
4,593
-43.3%
0.06%
-40.2%
Q3 2014$1,932,000
+18.2%
8,099
-48.4%
0.10%
-12.1%
Q1 2014$1,635,000
+165.0%
15,698
+36.5%
0.12%
+136.7%
Q3 2013$617,000
+61.5%
11,500
+33.7%
0.05%
+8.9%
Q2 2013$382,0008,6000.04%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 507,500$121,074,00024.90%
BB BIOTECH AG 476,991$113,796,0004.63%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$1,356,668,0003.35%
WEATHERBIE CAPITAL, LLC 101,055$24,109,0002.26%
Avalon Global Asset Management LLC 16,000$3,817,0002.24%
Redmile Group, LLC 51,025$12,173,0001.41%
Fernwood Investment Management, LLC 6,700$1,598,0001.38%
Iguana Healthcare Management, LLC 10,000$2,386,0001.27%
LMR Partners LLP 56,632$13,510,0001.08%
FRANKLIN STREET ADVISORS INC /NC 21,990$5,246,0001.00%
View complete list of PUMA BIOTECHNOLOGY INC shareholders